MedPath

AvKare, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

353

FDA:353

Drug Approvals

Benazepril Hydrochloride

Approval Date
Sep 23, 2025
FDA

Mirtazapine

Approval Date
Sep 23, 2025
FDA

Nystatin

Approval Date
Sep 18, 2025
FDA

Acebutolol Hydrochloride

Approval Date
Sep 18, 2025
FDA

Norethindrone Acetate

Approval Date
Sep 17, 2025
FDA

Meloxicam

Approval Date
Sep 16, 2025
FDA

Aripiprazole

Approval Date
Aug 26, 2025
FDA

Zafirlukast

Approval Date
Jul 31, 2025
FDA

Mirtazapine

Approval Date
May 20, 2025
FDA

Ondansetron

Approval Date
May 15, 2025
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 36
  • Next

Clinical Trials

No trials found

News

FDA Recalls Nearly 76,000 Cases of Eye Care Products Due to Manufacturing Deviations

The FDA has issued a recall for approximately 76,000 cases of over-the-counter ophthalmic products following an audit that revealed significant manufacturing deviations at BRS Analytical Services.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.